Spots Global Cancer Trial Database for experimental
Every month we try and update this database with for experimental cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Adjuvant TRastuzumab Deruxtecan for HER2-positive Gastroesophageal Cancer With Persistence of miNImal Residual Disease | NCT06253650 | Gastric Cancer HER2-positive G... | Experimental Control | 18 Years - | Gruppo Oncologico del Nord-Ovest | |
| Phase II Trial of Peginterferon Alpha-2b and Thalidomide in Adults With Recurrent Gliomas | NCT00047879 | Glioma | PEG-interferon ... Thalidomide | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Home-based Cervical Cancer Screening Project | NCT06166420 | Cervical Cancer | Experimental Active comparat... | 30 Years - 49 Years | University Hospital, Geneva | |
| Heavy Strength Training in Head and Neck Cancer Survivors | NCT06289049 | Head and Neck N... Head and Neck C... Head and Neck S... Head and Neck C... | Experimental | 18 Years - | University of Alberta | |
| Icotinib as First-line and Maintenance Treatment in EGFR Mutated Patients With Lung Adenocarcinoma | NCT01665417 | EGFR Positive N... Adenocarcinoma | Experimental Chemotherapy Chemotherapy | 18 Years - 70 Years | Betta Pharmaceuticals Co., Ltd. | |
| Study of Propranolol in Newly Diagnosed Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy | NCT01847001 | Locally Advance... Breast Cancer | Propranolol DOT imaging Paclitaxel Nab-paclitaxel Trastuzumab Pertuzumab Doxorubicin Cyclophosphamid... Surgery Premedication Anti-nausea the... Pegfilgrastim | 18 Years - | Columbia University | |
| Study of Propranolol in Newly Diagnosed Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy | NCT01847001 | Locally Advance... Breast Cancer | Propranolol DOT imaging Paclitaxel Nab-paclitaxel Trastuzumab Pertuzumab Doxorubicin Cyclophosphamid... Surgery Premedication Anti-nausea the... Pegfilgrastim | 18 Years - | Columbia University | |
| Adjuvant TRastuzumab Deruxtecan for HER2-positive Gastroesophageal Cancer With Persistence of miNImal Residual Disease | NCT06253650 | Gastric Cancer HER2-positive G... | Experimental Control | 18 Years - | Gruppo Oncologico del Nord-Ovest | |
| Chidamide for Patients With Relapse or Refractory Diffuse Large B-Cell Lymphoma and Follicular Lymphoma | NCT03410004 | Experimental | Chidamide | 18 Years - 75 Years | ChineseAMS | |
| Safety and Tolerability Study of FolateImmune in Combination With Cytokines in Patients With Refractory or Metastatic Cancer | NCT00329368 | Cancer | EC90 (KLH-FITC) GPI-0100 EC17 (Folate-FI... Interleukin-2 Interferon-alph... | 18 Years - | Endocyte | |
| Study of Vintafolide (MK-8109, EC145) for the Treatment of Recurrent or Refractory Solid Tumors (MK-8109-006, EC-FV-01) | NCT00308269 | Cancer | Vintafolide IV ... Vintafolide IV ... | 18 Years - | Endocyte | |
| Breast and Melanoma Trial With Lymphoseek to Identify Lymph Nodes | NCT01106040 | Breast Cancer Melanoma | Lymphoseek | 18 Years - | Navidea Biopharmaceuticals | |
| Phase II Trial of Peginterferon Alpha-2b and Thalidomide in Adults With Recurrent Gliomas | NCT00047879 | Glioma | PEG-interferon ... Thalidomide | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Study of EC0225 for the Treatment of Refractory or Metastatic Tumors | NCT00441870 | Cancer | EC0225, for Inj... 99mTC-EC20 (Fol... | 18 Years - | Endocyte | |
| Safety and Tolerability Study of FolateImmune in Combination With Cytokines in Patients With Refractory or Metastatic Cancer | NCT00329368 | Cancer | EC90 (KLH-FITC) GPI-0100 EC17 (Folate-FI... Interleukin-2 Interferon-alph... | 18 Years - | Endocyte | |
| NCGENES: North Carolina Clinical Genomic Evaluation by NextGen Exome Sequencing | NCT01969370 | Cancer Cardiovascular ... Neurologic Dysf... Congenital Abno... Hearing Loss | Experimental | - | University of North Carolina, Chapel Hill | |
| Study of Vintafolide (MK-8109, EC145) for the Treatment of Recurrent or Refractory Solid Tumors (MK-8109-006, EC-FV-01) | NCT00308269 | Cancer | Vintafolide IV ... Vintafolide IV ... | 18 Years - | Endocyte | |
| Clinical Study of Short-course Radiotherapy Followed by Fruquintinib Plus Sintilimab vs Bevacizumab Plus Capecitabine as First Line Treatment in Advanced mCRC | NCT06195670 | CRC Metastatic Colo... Metastatic Colo... | Experimental Active Comparat... | 18 Years - 85 Years | Zhejiang Cancer Hospital | |
| Evaluating Whether Charity Incentives Motive Cancer Survivors to Increase Physical Activity | NCT03322059 | Cancer Physical Activi... Incentives | Experimental Control | 18 Years - 50 Years | California Polytechnic State University-San Luis Obispo | |
| NCGENES: North Carolina Clinical Genomic Evaluation by NextGen Exome Sequencing | NCT01969370 | Cancer Cardiovascular ... Neurologic Dysf... Congenital Abno... Hearing Loss | Experimental | - | University of North Carolina, Chapel Hill | |
| Study of EC0489 for the Treatment of Refractory or Metastatic Tumors | NCT00852189 | Cancer | EC0489, Injecti... EC20 EC0489, Injecti... | 18 Years - | Endocyte | |
| Heavy Strength Training in Head and Neck Cancer Survivors | NCT06289049 | Head and Neck N... Head and Neck C... Head and Neck S... Head and Neck C... | Experimental | 18 Years - | University of Alberta | |
| Breast and Melanoma Trial With Lymphoseek to Identify Lymph Nodes | NCT01106040 | Breast Cancer Melanoma | Lymphoseek | 18 Years - | Navidea Biopharmaceuticals | |
| NCGENES: North Carolina Clinical Genomic Evaluation by NextGen Exome Sequencing | NCT01969370 | Cancer Cardiovascular ... Neurologic Dysf... Congenital Abno... Hearing Loss | Experimental | - | University of North Carolina, Chapel Hill | |
| Safety and Tolerability Study of FolateImmune in Combination With Cytokines in Patients With Refractory or Metastatic Cancer | NCT00329368 | Cancer | EC90 (KLH-FITC) GPI-0100 EC17 (Folate-FI... Interleukin-2 Interferon-alph... | 18 Years - | Endocyte | |
| Study of EC0489 for the Treatment of Refractory or Metastatic Tumors | NCT00852189 | Cancer | EC0489, Injecti... EC20 EC0489, Injecti... | 18 Years - | Endocyte | |
| Prospective, Observational Study on the Carotid Intima-media Thickness in Patients Undergoing Thyroid Surgery | NCT05774535 | Plummer Disease Multinodular Go... Graves Disease Hyperthyroidism Euthyroid Goite... Thyroid Cancer Basedow Disease | Experimental | 18 Years - 100 Years | Istituto Auxologico Italiano | |
| Study of Propranolol in Newly Diagnosed Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy | NCT01847001 | Locally Advance... Breast Cancer | Propranolol DOT imaging Paclitaxel Nab-paclitaxel Trastuzumab Pertuzumab Doxorubicin Cyclophosphamid... Surgery Premedication Anti-nausea the... Pegfilgrastim | 18 Years - | Columbia University | |
| Development of a Personalized Discussion Prioritization Tool for Older Adults Considering Adjuvant Chemotherapy for Breast Cancer | NCT05073432 | Breast Cancer | Experimental | 65 Years - | University of Rochester | |
| Study of EC0225 for the Treatment of Refractory or Metastatic Tumors | NCT00441870 | Cancer | EC0225, for Inj... 99mTC-EC20 (Fol... | 18 Years - | Endocyte | |
| Study of EC0225 for the Treatment of Refractory or Metastatic Tumors | NCT00441870 | Cancer | EC0225, for Inj... 99mTC-EC20 (Fol... | 18 Years - | Endocyte | |
| Prospective, Observational Study on the Carotid Intima-media Thickness in Patients Undergoing Thyroid Surgery | NCT05774535 | Plummer Disease Multinodular Go... Graves Disease Hyperthyroidism Euthyroid Goite... Thyroid Cancer Basedow Disease | Experimental | 18 Years - 100 Years | Istituto Auxologico Italiano | |
| Prospective, Observational Study on the Carotid Intima-media Thickness in Patients Undergoing Thyroid Surgery | NCT05774535 | Plummer Disease Multinodular Go... Graves Disease Hyperthyroidism Euthyroid Goite... Thyroid Cancer Basedow Disease | Experimental | 18 Years - 100 Years | Istituto Auxologico Italiano | |
| Chidamide for Patients With Relapse or Refractory Diffuse Large B-Cell Lymphoma and Follicular Lymphoma | NCT03410004 | Experimental | Chidamide | 18 Years - 75 Years | ChineseAMS |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
